Clinical Trials Sponsored by Waldron’s Peak Physical Therapy
Total 1 results
-
University of Colorado, DenverTemple University; Virginia Commonwealth University; University of Colorado,... and other collaboratorsCompleted
Sponsors and Collaborators
- Sahar Salehi
- The People's Hospital of Guangxi Zhang Autonomous Region
- Hoersholm Hospital
- Klinikum Bad Woerishofen
- Kuwait University
- Kerstyn C. Zalesin, M.D.
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Egyptian Russian University
- Xiao-Ming Mao
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Jia Liu
- Van Boven, Robert W., M.D.
- Only For Children Pharmaceuticals
- Hopeful Aging
- Genuv Inc.
- Pancreatic Cancer UK
- Liming Cheng
- Royal Hobart Hospital Research Foundation (funding source)
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Marcus Vinícius Guimarães de Lacerda
- View Full List
Medical Conditions
- Airway Obstruction
- Advanced Gastric Cancer With Serosal Invasion
- Smith-Lemli-Opitz Syndrome
- Pancytopenia Due to Chemotherapy
- Global Health
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Caffeine Dosage
- Role of Vitamin D in IVF for Better Outcome
- Raynaud Secondary to Other Autoimmune Disease
- Autologous Haematopoietic Stem Cell Transplant
- Stereotype-threat
- Gait Variability; Elders; Fall; Re-education
- Secondary Hypertension to Endocrine Disorders
- Pulmonary Invasive Aspergillosis
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- High Perinatal Mortality
- Stage II Vulvar Cancer
- Enlarged Uterus
- Urinary Tract Carcinoma
- EHMT1
- View Full List
Drug Interventions
- LX4211 800 mg
- Ibudilast
- CAZ/AVI plus Aztreonam
- Vehicle Foam with UVA and UVB and visible light irradiation
- IBI318
- Iohexol Inj 300 MG/ML
- High-dose loop diuretics
- ACP-204
- Ustekinumab
- Androgen-deprivation Therapy (ADT)
- Naltrexone and bupropion SR
- RDEA3170 12 mg
- Jatenzo
- MC-1101
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- APD334
- Nystatin
- P276-00
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- Omalizumab Injection
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Armenia
- Contract Research Organizations in Belarus
- Contract Research Organizations in Colombia
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mexico
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Tunisia
- CRO list by country